1477 related articles for article (PubMed ID: 24041768)
1. Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.
Geldhof MF; Van Breedam W; De Jong E; Lopez Rodriguez A; Karniychuk UU; Vanhee M; Van Doorsselaere J; Maes D; Nauwynck HJ
Vet Microbiol; 2013 Dec; 167(3-4):260-71. PubMed ID: 24041768
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges.
Geldhof MF; Vanhee M; Van Breedam W; Van Doorsselaere J; Karniychuk UU; Nauwynck HJ
BMC Vet Res; 2012 Oct; 8():182. PubMed ID: 23031319
[TBL] [Abstract][Full Text] [Related]
3. Long-term administration of a commercial porcine reproductive and respiratory syndrome virus (PRRSV)-inactivated vaccine in PRRSV-endemically infected sows.
Papatsiros VG; Alexopoulos C; Kritas SK; Koptopoulos G; Nauwynck HJ; Pensaert MB; Kyriakis SC
J Vet Med B Infect Dis Vet Public Health; 2006 Aug; 53(6):266-72. PubMed ID: 16907957
[TBL] [Abstract][Full Text] [Related]
4. [The PRRSV-serumneutralization test detects gaps in herd immunity].
Böttcher J; Alex M; Janowetz B; Müller S; Schuh C; Niemeyer H
Berl Munch Tierarztl Wochenschr; 2014; 127(7-8):305-13. PubMed ID: 25080824
[TBL] [Abstract][Full Text] [Related]
5. Cross-protection of a modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine against a heterologous PRRSV-1 challenge in late-term pregnancy gilts.
Jeong J; Park C; Oh T; Park KH; Yang S; Kang I; Park SJ; Chae C
Vet Microbiol; 2018 Sep; 223():119-125. PubMed ID: 30173737
[TBL] [Abstract][Full Text] [Related]
6. Maternally-derived neutralizing antibodies reduce vaccine efficacy against porcine reproductive and respiratory syndrome virus infection.
Renson P; Fablet C; Andraud M; Normand V; Lebret A; Paboeuf F; Rose N; Bourry O
Vaccine; 2019 Jul; 37(31):4318-4324. PubMed ID: 31248683
[TBL] [Abstract][Full Text] [Related]
7. Ability of ELISAs to detect antibodies against porcine respiratory and reproductive syndrome virus in serum of pigs after inactivated vaccination and subsequent challenge.
Sattler T; Pikalo J; Wodak E; Schmoll F
BMC Vet Res; 2016 Nov; 12(1):259. PubMed ID: 27871292
[TBL] [Abstract][Full Text] [Related]
8. Immunologic responses and reproductive outcomes following exposure to wild-type or attenuated porcine reproductive and respiratory syndrome virus in swine under field conditions.
Lowe JF; Zuckermann FA; Firkins LD; Schnitzlein WM; Goldberg TL
J Am Vet Med Assoc; 2006 Apr; 228(7):1082-8. PubMed ID: 16579789
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of commercial genotype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine against field isolate of genotype 2 PRRSV.
Ko SS; Seo SW; Sunwoo SY; Yoo SJ; Kim MH; Lyoo YS
Vet Immunol Immunopathol; 2016 Apr; 172():43-9. PubMed ID: 27032502
[TBL] [Abstract][Full Text] [Related]
10. Impact of a novel inactivated PRRS virus vaccine on virus replication and virus-induced pathology in fetal implantation sites and fetuses upon challenge.
Karniychuk UU; Saha D; Vanhee M; Geldhof M; Cornillie P; Caij AB; De Regge N; Nauwynck HJ
Theriogenology; 2012 Oct; 78(7):1527-37. PubMed ID: 22980086
[TBL] [Abstract][Full Text] [Related]
11. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
Evenson D; Gerber PF; Xiao CT; Halbur PG; Wang C; Tian D; Ni YY; Meng XJ; Opriessnig T
Vaccine; 2016 Nov; 34(46):5546-5553. PubMed ID: 27742217
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with a porcine reproductive and respiratory syndrome virus vaccine at 1-day-old improved growth performance of piglets under field conditions.
Jeong J; Kim S; Park KH; Kang I; Park SJ; Yang S; Oh T; Chae C
Vet Microbiol; 2018 Feb; 214():113-124. PubMed ID: 29408022
[TBL] [Abstract][Full Text] [Related]
13. Inactivated porcine reproductive and respiratory syndrome virus vaccine adjuvanted with Montanide™ Gel 01 ST elicits virus-specific cross-protective inter-genotypic response in piglets.
Tabynov K; Sansyzbay A; Tulemissova Z; Tabynov K; Dhakal S; Samoltyrova A; Renukaradhya GJ; Mambetaliyev M
Vet Microbiol; 2016 Aug; 192():81-89. PubMed ID: 27527768
[TBL] [Abstract][Full Text] [Related]
14. A modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-1 vaccine protects late-term pregnancy gilts against heterologous PRRSV-1 but not PRRSV-2 challenge.
Jeong J; Kang I; Kim S; Park SJ; Park KH; Oh T; Yang S; Chae C
Transbound Emerg Dis; 2018 Oct; 65(5):1227-1234. PubMed ID: 29536637
[TBL] [Abstract][Full Text] [Related]
15. Development of an experimental inactivated PRRSV vaccine that induces virus-neutralizing antibodies.
Vanhee M; Delputte PL; Delrue I; Geldhof MF; Nauwynck HJ
Vet Res; 2009; 40(6):63. PubMed ID: 19674539
[TBL] [Abstract][Full Text] [Related]
16. Levels of neutralizing antibodies against resident farm strain or vaccine strain are not indicators of protection against PRRSV-1 vertical transmission under farm conditions.
Martin-Valls GE; Li Y; Clilverd H; Soto J; Cortey M; Mateu E
BMC Vet Res; 2023 Oct; 19(1):217. PubMed ID: 37858141
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection.
Ferrari L; Martelli P; Saleri R; De Angelis E; Cavalli V; Bresaola M; Benetti M; Borghetti P
Vet Immunol Immunopathol; 2013 Feb; 151(3-4):193-206. PubMed ID: 23228653
[TBL] [Abstract][Full Text] [Related]
18. Synthetic B- and T-cell epitope peptides of porcine reproductive and respiratory syndrome virus with Gp96 as adjuvant induced humoral and cell-mediated immunity.
Chen C; Li J; Bi Y; Yang L; Meng S; Zhou Y; Jia X; Meng S; Sun L; Liu W
Vaccine; 2013 Apr; 31(14):1838-47. PubMed ID: 23395588
[TBL] [Abstract][Full Text] [Related]
19. Intranasal immunization of pigs with porcine reproductive and respiratory syndrome virus-like particles plus 2', 3'-cGAMP VacciGrade™ adjuvant exacerbates viremia after virus challenge.
Van Noort A; Nelsen A; Pillatzki AE; Diel DG; Li F; Nelson E; Wang X
Virol J; 2017 Apr; 14(1):76. PubMed ID: 28403874
[TBL] [Abstract][Full Text] [Related]
20. Enhanced immune responses in pigs by DNA vaccine coexpressing GP3 and GP5 of European type porcine reproductive and respiratory syndrome virus.
Ren J; Lu H; Wen S; Sun W; Yan F; Chen X; Jing J; Liu H; Liu C; Xue F; Xiao P; Xin S; Jin N
J Virol Methods; 2014 Sep; 206():27-37. PubMed ID: 24882496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
